Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1749

1.

Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.

Patel MM, Parashar UD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S291-9. doi: 10.1086/605059. Review.

PMID:
19817612
2.

Rotavirus vaccines for infants in developing countries in Africa and Asia: considerations from a world health organization-sponsored consultation.

Steele AD, Patel M, Parashar UD, Victor JC, Aguado T, Neuzil KM.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S63-9. doi: 10.1086/605042.

PMID:
19817616
3.

Rotavirus vaccines: targeting the developing world.

Glass RI, Bresee JS, Turcios R, Fischer TK, Parashar UD, Steele AD.

J Infect Dis. 2005 Sep 1;192 Suppl 1:S160-6.

PMID:
16088799
4.

Global rotavirus surveillance: determining the need and measuring the impact of rotavirus vaccines.

Widdowson MA, Steele D, Vojdani J, Wecker J, Parashar U.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S1-8. doi: 10.1086/605061. Review.

PMID:
19817589
5.

Update on Rotarix: an oral human rotavirus vaccine.

O'Ryan M, Linhares AC.

Expert Rev Vaccines. 2009 Dec;8(12):1627-41. doi: 10.1586/erv.09.136. Review.

PMID:
19943758
6.

Rotarix in developing countries: paving the way for inclusion in national childhood immunization programs in Africa.

Pawinski R, Debrus S, Delem A, Smolenov I, Suryakiran PV, Han HH.

J Infect Dis. 2010 Sep 1;202 Suppl:S80-6. doi: 10.1086/653547.

PMID:
20684722
7.

Cost-effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico.

Valencia-Mendoza A, Bertozzi SM, Gutierrez JP, Itzler R.

BMC Infect Dis. 2008 Jul 29;8:103. doi: 10.1186/1471-2334-8-103.

8.

Global impact of rotavirus vaccines.

Tate JE, Patel MM, Steele AD, Gentsch JR, Payne DC, Cortese MM, Nakagomi O, Cunliffe NA, Jiang B, Neuzil KM, de Oliveira LH, Glass RI, Parashar UD.

Expert Rev Vaccines. 2010 Apr;9(4):395-407. doi: 10.1586/erv.10.17. Review. Erratum in: Expert Rev Vaccines. 2010 Jul;9(7):804.

PMID:
20370550
9.

Implementing rotavirus vaccination in Asia.

Santosham M, Nelson EA, Bresee JS.

Vaccine. 2007 Nov 1;25(44):7711-6. Epub 2007 Aug 22.

PMID:
17881099
10.

Rotavirus vaccines: update on global impact and future priorities.

Yen C, Tate JE, Patel MM, Cortese MM, Lopman B, Fleming J, Lewis K, Jiang B, Gentsch J, Steele D, Parashar UD.

Hum Vaccin. 2011 Dec;7(12):1282-90. doi: 10.4161/hv.7.12.18321. Epub 2011 Dec 1. Review.

11.

Rotavirus vaccines: opportunities and challenges.

Grimwood K, Lambert SB.

Hum Vaccin. 2009 Feb;5(2):57-69. Epub 2009 Feb 8. Review.

PMID:
18838873
12.

Economic evaluations of rotavirus immunization for developing countries: a review of the literature.

Tu HA, Woerdenbag HJ, Kane S, Rozenbaum MH, Li SC, Postma MJ.

Expert Rev Vaccines. 2011 Jul;10(7):1037-51. doi: 10.1586/erv.11.65. Review.

PMID:
21806398
13.

Rotarix®: vaccine performance 6 years postlicensure.

O'Ryan M, Lucero Y, Linhares AC.

Expert Rev Vaccines. 2011 Dec;10(12):1645-59. doi: 10.1586/erv.11.152. Review.

PMID:
22085167
14.

Effects of vaccine on rotavirus disease in the pediatric population.

Dennehy PH.

Curr Opin Pediatr. 2012 Feb;24(1):76-84. doi: 10.1097/MOP.0b013e32834ee594. Review.

PMID:
22189398
15.

A review of rotavirus infection in and vaccination of human immunodeficiency virus-infected children.

Steele AD, Cunliffe N, Tumbo J, Madhi SA, De Vos B, Bouckenooghe A.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S57-62. doi: 10.1086/605027. Review.

PMID:
19817615
16.

Projected Impact of the new rotavirus vaccination program on hospitalizations for gastroenteritis and rotavirus disease among US children <5 years of age during 2006-2015.

Curns AT, Coffin F, Glasser JW, Glass RI, Parashar UD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S49-56. doi: 10.1086/605036.

PMID:
19817614
17.

Projected cost-effectiveness of rotavirus vaccination for children in Asia.

Podewils LJ, Antil L, Hummelman E, Bresee J, Parashar UD, Rheingans R.

J Infect Dis. 2005 Sep 1;192 Suppl 1:S133-45.

PMID:
16088797
18.

Economics of rotavirus gastroenteritis and vaccination in Europe: what makes sense?

Rheingans RD, Heylen J, Giaquinto C.

Pediatr Infect Dis J. 2006 Jan;25(1 Suppl):S48-55. Review.

PMID:
16397429
19.

First rotavirus vaccine licensed: is there really a need?

Glass RI, Bresee JS, Parashar UD, Holman RC, Gentsch JR.

Acta Paediatr Suppl. 1999 Jan;88(426):2-8. Review.

PMID:
10088904
20.

RotaTeq: a three-dose oral pentavalent reassortant rotavirus vaccine.

Chandran A, Santosham M.

Expert Rev Vaccines. 2008 Dec;7(10):1475-80. doi: 10.1586/14760584.7.10.1475. Review.

PMID:
19053204

Supplemental Content

Support Center